Long-Term Followup of Penile Carcinoma With High Risk for Lymph Node Invasion Treated With Inguinal Lymphadenectomy

Journal of Urology

Volumn 183, Issue 6, 2010, Pages 2227-2232

  Marconnet, Louis ^a   Rigaud, Jérôme ^a   Bouchot, Olivier ^a  

^a HÔTEL DIEU   (France)

Author keywords

carcinoma; lymph node excision; lymph nodes; mortality; penis; squamous cell

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PENIS CARCINOMA; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; INGUINAL CANAL; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PENILE NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 77951877932     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.02.025     Document Type: Article

References (28)

1. McDougal W.S., Kirchner Jr. F.K., Edwards R.H., et al. Treatment of carcinoma of the penis: the case for primary lymphadenectomy. J Urol 136 (1986) 38
2. Persky L., and deKernion J. Carcinoma of the penis. CA Cancer J Clin 36 (1986) 258
3. Pow-Sang J.E., Benavente V., Pow-Sang J.M., et al. Bilateral ilioinguinal lymph node dissection in the management of cancer of the penis. Semin Surg Oncol 6 (1990) 241
4. Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 72 (1993) 817
5. Soria J.C., Fizazi K., Piron D., et al. Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy. Ann Oncol 8 (1997) 1089
6. Srinivas V., Morse M.J., Herr H.W., et al. Penile cancer: relation of extent of nodal metastasis to survival. J Urol 137 (1987) 880
7. Horenblas S., and van Tinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol 151 (1994) 1239
8. Lopes A., Hidalgo G.S., Kowalski L.P., et al. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 156 (1996) 1637
9. Solsona E., Iborra I., Ricos J.V., et al. Corpus cavernosum invasion and tumor grade in the prediction of lymph node condition in penile carcinoma. Eur Urol 22 (1992) 115
10. Solsona E., Algaba F., Horenblas S., et al. EAU Guidelines on Penile Cancer. Eur Urol 46 (2004) 1
11. Kroon B.K., Horenblas S., Meinhardt W., et al. Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol 47 (2005) 601
12. Catalona W.J. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. J Urol 140 (1988) 306
13. Lynch D., and Pettaway C. Tumors of the penis. In: Walsh P.C., Retik A.B., and Vaughan Jr. E.D. (Eds). Campbell's Urology. 8th ed. vol 4 (2002), Saunders, Philadelphia 2945
14. Lont A.P., Kroon B.K., Gallee M.P., et al. Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 177 (2007) 947
15. Leijte J.A., Gallee M., Antonini N., et al. Evaluation of current TNM classification of penile carcinoma. J Urol 180 (2008) 933
16. d'Ancona C.A., de Lucena R.G., Querne F.A., et al. Long-term followup of penile carcinoma treated with penectomy and bilateral modified inguinal lymphadenectomy. J Urol 172 (2004) 498
17. Lopes A., Rossi B.M., Fonseca F.P., et al. Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma. Cancer 77 (1996) 2099
18. Parra R.O. Accurate staging of carcinoma of the penis in men with nonpalpable inguinal lymph nodes by modified inguinal lymphadenectomy. J Urol 155 (1996) 560
19. Colberg J.W., Andriole G.L., and Catalona W.J. Long-term follow-up of men undergoing modified inguinal lymphadenectomy for carcinoma of the penis. Br J Urol 79 (1997) 54
20. Leijte J.A., Kirrander P., Antonini N., et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 54 (2008) 161
21. Leijte J.A., Valdes Olmos R.A., Nieweg O.E., et al. Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: implications for the extent of inguinal lymph node dissection. Eur Urol 54 (2008) 885
22. Bouchot O., Auvigne J., Peuvrel P., et al. Management of regional lymph nodes in carcinoma of the penis. Eur Urol 16 (1989) 410
23. Pedrick T.J., Wheeler W., and Riemenschneider H. Combined modality therapy for locally advanced penile squamous cell carcinoma. Am J Clin Oncol 16 (1993) 501
24. Shammas F.V., Ous S., and Fossa S.D. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 147 (1992) 630
25. Pizzocaro G., and Piva L. Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27 (1988) 823
26. Bermejo C., Busby J.E., Spiess P.E., et al. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177 (2007) 1335
27. Leijte J.A., Kerst J.M., Bais E., et al. Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 52 (2007) 488
28. Bouchot O., and Rigaud J. Penis tumours: techniques and indications. Ann Urol (Paris) 38 (2004) 285